reference/32756487

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32756487

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	292
issn	1526-9655
issueIdentifier	4
pageRange	285-292
publicationName	Clinical Lymphoma
startingPage	285
bibliographicCitation	Wilder DD, Ogden JL, Jain VK. A multicenter trial of infusional etoposide, doxorubicin, and vincristine with cyclophosphamide and prednisone (EPOCH) in patients with relapsed non-Hodgkin's lymphoma. Clin Lymphoma. 2001 Mar;1(4):285–92. doi: 10.3816/clm.2001.n.003. PMID: 11707843.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_caa2612ecfd1521fde6d4cad32c2d33f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0d73f0fe186a00b7fb90fee2a8f9c7e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4b215601e28c45264a88397c8d461a1
date	200103
identifier	https://pubmed.ncbi.nlm.nih.gov/11707843 https://doi.org/10.3816/clm.2001.n.003
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/26790 https://portal.issn.org/resource/ISSN/1526-9655
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A Multicenter Trial of Infusional Etoposide, Doxorubicin, and Vincristine with Cyclophosphamide and Prednisone (EPOCH) in Patients with Relapsed Non-Hodgkin's Lymphoma
discusses	http://id.nlm.nih.gov/mesh/M0132467 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0010685 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0009659 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0007930
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011241Q000627 http://id.nlm.nih.gov/mesh/D004317Q000627 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D003520Q000627 http://id.nlm.nih.gov/mesh/D014750Q000627 http://id.nlm.nih.gov/mesh/D005047Q000627 http://id.nlm.nih.gov/mesh/D008228Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006836Q000378 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006133Q000378 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D009503Q000188 http://id.nlm.nih.gov/mesh/D009364 http://id.nlm.nih.gov/mesh/D009503Q000139 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004351 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008228Q000175 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D008228Q000401 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23480 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7078 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281

Total number of triples: 74.